215 related articles for article (PubMed ID: 27712796)
1. Metastasis in Adult Brain Tumors.
Barajas RF; Cha S
Neuroimaging Clin N Am; 2016 Nov; 26(4):601-620. PubMed ID: 27712796
[TBL] [Abstract][Full Text] [Related]
2. Imaging diagnosis of brain metastasis.
Barajas RF; Cha S
Prog Neurol Surg; 2012; 25():55-73. PubMed ID: 22236668
[TBL] [Abstract][Full Text] [Related]
3. Lymphomas-Part 1.
Brandão LA; Castillo M
Neuroimaging Clin N Am; 2016 Nov; 26(4):511-536. PubMed ID: 27712792
[TBL] [Abstract][Full Text] [Related]
4. Advanced MR Imaging in Pediatric Brain Tumors, Clinical Applications.
Lequin M; Hendrikse J
Neuroimaging Clin N Am; 2017 Feb; 27(1):167-190. PubMed ID: 27889022
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice.
Boxerman JL; Shiroishi MS; Ellingson BM; Pope WB
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):649-670. PubMed ID: 27742108
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
Abdel Razek AA; Samir S; Ashmalla GA
J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
[TBL] [Abstract][Full Text] [Related]
8. Contrast enhancement in primary tumors of the brain and spinal cord.
Castillo M
Neuroimaging Clin N Am; 1994 Feb; 4(1):63-80. PubMed ID: 8130953
[TBL] [Abstract][Full Text] [Related]
9. Advanced MR Imaging Techniques in Daily Practice.
Mabray MC; Cha S
Neuroimaging Clin N Am; 2016 Nov; 26(4):647-666. PubMed ID: 27712798
[TBL] [Abstract][Full Text] [Related]
10. Molecular Imaging of Brain Tumors Using Liposomal Contrast Agents and Nanoparticles.
Mehta A; Ghaghada K; Mukundan S
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):751-763. PubMed ID: 27742115
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
12. Imaging of brain tumors.
Chourmouzi D; Papadopoulou E; Marias K; Drevelegas A
Surg Oncol Clin N Am; 2014 Oct; 23(4):629-84. PubMed ID: 25246045
[TBL] [Abstract][Full Text] [Related]
13. [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].
Weber MA; Risse F; Giesel FL; Schad LR; Kauczor HU; Essig M
Radiologe; 2005 Jul; 45(7):618-32. PubMed ID: 15098092
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
15. Clinical Review of Computed Tomography and MR Perfusion Imaging in Neuro-Oncology.
Trinh A; Wintermark M; Iv M
Radiol Clin North Am; 2021 May; 59(3):323-334. PubMed ID: 33926680
[TBL] [Abstract][Full Text] [Related]
16. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
17. Primary Neoplasms of the Pediatric Brain.
Jaimes C; Poussaint TY
Radiol Clin North Am; 2019 Nov; 57(6):1163-1175. PubMed ID: 31582042
[TBL] [Abstract][Full Text] [Related]
18. Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease.
Cavallin L; Axelsson R; Wahlund LO; Oksengard AR; Svensson L; Juhlin P; Wiberg MK; Frank A
Acta Radiol; 2008 Dec; 49(10):1154-61. PubMed ID: 18855165
[TBL] [Abstract][Full Text] [Related]
19. [Brain metastases imaging].
Delmaire C; Savatovsky J; Boulanger T; Dhermain F; Le Rhun E; Météllus P; Gerber S; Carsin-Nicole B; Petyt G
Cancer Radiother; 2015 Feb; 19(1):16-9. PubMed ID: 25649387
[TBL] [Abstract][Full Text] [Related]
20. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
Jain R
NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
